Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

The TGFβ-ERK pathway contributes to Notch3 upregulation in the renal tubular epithelial cells of patients with obstructive nephropathy.

Huang M, Zhang J, Xu H, Ding T, Tang D, Yuan Q, Tao L, Ye Z.

Cell Signal. 2018 Nov;51:139-151. doi: 10.1016/j.cellsig.2018.08.002. Epub 2018 Aug 4.

PMID:
30081092
2.

Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence.

Jiang Y, Mei W, Gu Y, Lin X, He L, Zeng H, Wei F, Wan X, Yang H, Major P, Tang D.

Mol Oncol. 2018 Sep;12(9):1559-1578. doi: 10.1002/1878-0261.12359. Epub 2018 Aug 11.

3.

Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development.

Gu Y, Chow MJ, Kapoor A, Mei W, Jiang Y, Yan J, De Melo J, Seliman M, Yang H, Cutz JC, Bonert M, Major P, Tang D.

Transl Oncol. 2018 Aug;11(4):1012-1022. doi: 10.1016/j.tranon.2018.06.003. Epub 2018 Jun 30.

4.

Etoposide-induced DNA damage affects multiple cellular pathways in addition to DNA damage response.

Wei F, Hao P, Zhang X, Hu H, Jiang D, Yin A, Wen L, Zheng L, He JZ, Mei W, Zeng H, Tang D.

Oncotarget. 2018 Feb 16;9(35):24122-24139. doi: 10.18632/oncotarget.24517. eCollection 2018 May 8.

5.

Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer.

Ojo D, Lin X, Wu Y, Cockburn J, Bane A, Tang D.

Cancer Lett. 2018 Jul 10;426:4-13. doi: 10.1016/j.canlet.2018.03.048. Epub 2018 Apr 4.

PMID:
29626519
6.

A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer.

Ojo D, Wu Y, Bane A, Tang D.

Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):735-745. doi: 10.1016/j.bbadis.2017.12.018. Epub 2017 Dec 14.

PMID:
29248549
7.

Next Generation Quality: Assessing the Physician in Clinical History Completeness and Diagnostic Interpretations Using Funnel Plots and Normalized Deviations Plots in 3,854 Prostate Biopsies.

Bonert M, El-Shinnawy I, Carvalho M, Williams P, Salama S, Tang D, Kapoor A.

J Pathol Inform. 2017 Nov 23;8:43. doi: 10.4103/jpi.jpi_50_17. eCollection 2017.

8.

BMI1 reduces ATR activation and signalling caused by hydroxyurea.

Lin X, Wei F, Whyte P, Tang D.

Oncotarget. 2017 Sep 20;8(52):89707-89721. doi: 10.18632/oncotarget.21111. eCollection 2017 Oct 27.

9.

Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression.

Lin X, Gu Y, Kapoor A, Wei F, Aziz T, Ojo D, Jiang Y, Bonert M, Shayegan B, Yang H, Al-Nedawi K, Major P, Tang D.

Neoplasia. 2017 Nov;19(11):857-867. doi: 10.1016/j.neo.2017.06.006. Epub 2017 Sep 18.

10.

Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer.

Ojo D, Seliman M, Tang D.

BBA Clin. 2017 Aug 24;8:56-65. doi: 10.1016/j.bbacli.2017.07.004. eCollection 2017 Dec.

11.

Microvesicles Contribute to the Bystander Effect of DNA Damage.

Lin X, Wei F, Major P, Al-Nedawi K, Al Saleh HA, Tang D.

Int J Mol Sci. 2017 Apr 7;18(4). pii: E788. doi: 10.3390/ijms18040788.

12.

Upregulation of FAM84B during prostate cancer progression.

Wong N, Gu Y, Kapoor A, Lin X, Ojo D, Wei F, Yan J, de Melo J, Major P, Wood G, Aziz T, Cutz JC, Bonert M, Patterson AJ, Tang D.

Oncotarget. 2017 Mar 21;8(12):19218-19235. doi: 10.18632/oncotarget.15168.

13.

Amplification of MUC1 in prostate cancer metastasis and CRPC development.

Wong N, Major P, Kapoor A, Wei F, Yan J, Aziz T, Zheng M, Jayasekera D, Cutz JC, Chow MJ, Tang D.

Oncotarget. 2016 Dec 13;7(50):83115-83133. doi: 10.18632/oncotarget.13073.

14.

Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycle.

Xie Y, Shen YT, Kapoor A, Ojo D, Wei F, De Melo J, Lin X, Wong N, Yan J, Tao L, Major P, Tang D.

Data Brief. 2016 Jan 28;6:811-6. doi: 10.1016/j.dib.2016.01.036. eCollection 2016 Mar.

15.

Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.

Yan J, Ojo D, Kapoor A, Lin X, Pinthus JH, Aziz T, Bismar TA, Wei F, Wong N, De Melo J, Cutz JC, Major P, Wood G, Peng H, Tang D.

Cancer Res. 2016 Mar 15;76(6):1603-14. doi: 10.1158/0008-5472.CAN-15-1898. Epub 2016 Jan 21.

16.

CYB5D2 displays tumor suppression activities towards cervical cancer.

Xie Y, Shen YT, Kapoor A, Ojo D, Wei F, De Melo J, Lin X, Wong N, Yan J, Tao L, Major P, Tang D.

Biochim Biophys Acta. 2016 Apr;1862(4):556-565. doi: 10.1016/j.bbadis.2015.12.013. Epub 2015 Dec 12.

17.

Hematoporphyrin monomethyl ether combined with He-Ne laser irradiation-induced apoptosis in canine breast cancer cells through the mitochondrial pathway.

Li H, Tong J, Bao J, Tang D, Tian W, Liu Y.

J Vet Sci. 2016 Jun 30;17(2):235-42. doi: 10.4142/jvs.2016.17.2.235.

18.

A Novel Aspect of Tumorigenesis-BMI1 Functions in Regulating DNA Damage Response.

Lin X, Ojo D, Wei F, Wong N, Gu Y, Tang D.

Biomolecules. 2015 Dec 1;5(4):3396-415. doi: 10.3390/biom5043396. Review.

19.

Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer.

Ojo D, Lin X, Wong N, Gu Y, Tang D.

Cancers (Basel). 2015 Nov 18;7(4):2290-308. doi: 10.3390/cancers7040890. Review.

20.

BMI1, ATM and DDR.

Lin X, Gu Y, Tang D.

Oncoscience. 2015 Aug 21;2(8):665-6. eCollection 2015. No abstract available.

Supplemental Content

Loading ...
Support Center